BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tatapudi RR, Muthukumar T, Dadhania D, Ding R, Li B, Sharma VK, Lozada-Pastorio E, Seetharamu N, Hartono C, Serur D. Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. Kidney Int. 2004;65:2390-2397. [PMID: 15149352 DOI: 10.1111/j.1523-1755.2004.00663.x] [Cited by in Crossref: 150] [Cited by in F6Publishing: 139] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Raulf F. Novel biomarkers of allograft rejection: ???omics??? approaches start to deliver: . Current Opinion in Organ Transplantation 2005;10:295-300. [DOI: 10.1097/01.mot.0000184016.85831.dc] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Zerwes H, Li J, Kovarik J, Streiff M, Hofmann M, Roth L, Luyten M, Pally C, Loewe RP, Wieczorek G, Bänteli R, Thoma G, Luckow B. The Chemokine Receptor Cxcr3 Is Not Essential for Acute Cardiac Allograft Rejection in Mice and Rats. American Journal of Transplantation 2008;8:1604-13. [DOI: 10.1111/j.1600-6143.2008.02309.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
3 Fischereder M. Chemokines and chemokine receptors in renal transplantation — from bench to bedside. Acta Physiologica Hungarica 2007;94:67-81. [DOI: 10.1556/aphysiol.94.2007.1-2.7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
4 Merhi B, Bayliss G, Gohh RY. Role for urinary biomarkers in diagnosis of acute rejection in the transplanted kidney. World J Transplant 2015; 5(4): 251-260 [PMID: 26722652 DOI: 10.5500/wjt.v5.i4.251] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
5 Nickerson P. Post-transplant monitoring of renal allografts: are we there yet? Curr Opin Immunol 2009;21:563-8. [PMID: 19713093 DOI: 10.1016/j.coi.2009.07.014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
6 Snopkowski C, Salinas T, Li C, Stryjniak G, Ding R, Sharma V, Suthanthiran M. Urinary cell mRNA profiling of kidney allograft recipients: A systematic investigation of a filtration based protocol for the simplification of urine processing. J Immunol Methods 2021;498:113132. [PMID: 34464607 DOI: 10.1016/j.jim.2021.113132] [Reference Citation Analysis]
7 Weseslindtner L, Hedman L, Wang Y, Strassl R, Helanterä I, Aberle SW, Bond G, Hedman K. Longitudinal assessment of the CXCL10 blood and urine concentration in kidney transplant recipients with BK polyomavirus replication-a retrospective study. Transpl Int 2020;33:555-66. [PMID: 31981424 DOI: 10.1111/tri.13584] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
8 Ting YT, Coates PT, Marti HP, Dunn AC, Parker RM, Pickering JW, Jack RW, Kemp RA, Walker RJ, McLellan AD. Urinary soluble HLA-DR is a potential biomarker for acute renal transplant rejection. Transplantation 2010;89:1071-8. [PMID: 20098353 DOI: 10.1097/TP.0b013e3181d15492] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Dharnidharka VR, Malone A. Biomarkers to detect rejection after kidney transplantation. Pediatr Nephrol 2018;33:1113-22. [PMID: 28631040 DOI: 10.1007/s00467-017-3712-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
10 Muthukumar T, Lee JR, Dadhania DM, Ding R, Sharma VK, Schwartz JE, Suthanthiran M. Allograft rejection and tubulointerstitial fibrosis in human kidney allografts: interrogation by urinary cell mRNA profiling. Transplant Rev (Orlando). 2014;28:145-154. [PMID: 24929703 DOI: 10.1016/j.trre.2014.05.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
11 Spivey TL, Uccellini L, Ascierto ML, Zoppoli G, De Giorgi V, Delogu LG, Engle AM, Thomas JM, Wang E, Marincola FM, Bedognetti D. Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis. J Transl Med 2011;9:174. [PMID: 21992116 DOI: 10.1186/1479-5876-9-174] [Cited by in Crossref: 68] [Cited by in F6Publishing: 68] [Article Influence: 6.2] [Reference Citation Analysis]
12 Thomson AW, Fairchild RL. The Last 5 Years of Basic Science Investigation in Transplant Immunology. Am J Transplant 2006;6:1768-73. [DOI: 10.1111/j.1600-6143.2006.01424.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
13 Muthukumar T, Afaneh C, Ding R, Tsapepas D, Lubetzky M, Jacobs S, Lee J, Sharma V, Lee J, Dadhania D, Hartono C, McDermott J, Aull M, Leeser D, Kapur S, Serur D, Suthanthiran M. HIV-infected kidney graft recipients managed with an early corticosteroid withdrawal protocol: clinical outcomes and messenger RNA profiles. Transplantation 2013;95:711-20. [PMID: 23503504 DOI: 10.1097/TP.0b013e31827ac322] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
14 Kariminik A, Dabiri S, Yaghobi R. Polyomavirus BK Induces Inflammation via Up-regulation of CXCL10 at Translation Levels in Renal Transplant Patients with Nephropathy. Inflammation 2016;39:1514-9. [DOI: 10.1007/s10753-016-0385-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
15 Hricik DE, Nickerson P, Formica RN, Poggio ED, Rush D, Newell KA, Goebel J, Gibson IW, Fairchild RL, Riggs M. Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury. Am J Transplant. 2013;13:2634-2644. [PMID: 23968332 DOI: 10.1111/ajt.12426] [Cited by in Crossref: 153] [Cited by in F6Publishing: 130] [Article Influence: 17.0] [Reference Citation Analysis]
16 Alsuwaida A, Husain S, Alghonaim M, AlOudah N, Alwakeel J, ullah A, Kfoury H. Strategy for second kidney biopsy in patients with lupus nephritis. Nephrol Dial Transplant 2012;27:1472-8. [PMID: 21931127 DOI: 10.1093/ndt/gfr517] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
17 Hernandez-Fuentes MP, Lechler RI. A 'biomarker signature' for tolerance in transplantation. Nat Rev Nephrol 2010;6:606-13. [PMID: 20717098 DOI: 10.1038/nrneph.2010.112] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
18 Pereira AB, Teixeira AL, Rezende NA, Pereira RM, Miranda DM, Oliveira EA, Teixeira MM, Simões E Silva AC. Urinary chemokines and anti-inflammatory molecules in renal transplanted patients as potential biomarkers of graft function: a prospective study. Int Urol Nephrol 2012;44:1539-48. [PMID: 22544449 DOI: 10.1007/s11255-012-0176-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
19 Anglicheau D, Sharma VK, Ding R, Hummel A, Snopkowski C, Dadhania D, Seshan SV, Suthanthiran M. MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci USA. 2009;106:5330-5335. [PMID: 19289845 DOI: 10.1073/pnas.0813121106] [Cited by in Crossref: 250] [Cited by in F6Publishing: 239] [Article Influence: 19.2] [Reference Citation Analysis]
20 Chakraborty A, Sarwal M. Protein biomarkers in renal transplantation. Expert Review of Proteomics 2018;15:41-54. [DOI: 10.1080/14789450.2018.1396892] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
21 Blydt-hansen TD, Sharma A, Gibson IW, Mandal R, Wishart DS. Urinary Metabolomics for Noninvasive Detection of Borderline and Acute T Cell-Mediated Rejection in Children After Kidney Transplantation: Urinary Metabolomics and Transplant Rejection. American Journal of Transplantation 2014;14:2339-49. [DOI: 10.1111/ajt.12837] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 5.9] [Reference Citation Analysis]
22 Sigdel TK, Yang JYC, Bestard O, Schroeder A, Hsieh SC, Liberto JM, Damm I, Geraedts ACM, Sarwal MM. A urinary Common Rejection Module (uCRM) score for non-invasive kidney transplant monitoring. PLoS One. 2019;14:e0220052. [PMID: 31365568 DOI: 10.1371/journal.pone.0220052] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
23 Peng W, Chen J, Jiang Y, Wu J, Shou Z, He Q, Wang Y, Chen Y, Wang H. Urinary fractalkine is a marker of acute rejection. Kidney International 2008;74:1454-60. [DOI: 10.1038/ki.2008.459] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
24 Fairchild RL, Suthanthiran M. Urine CXCL10/IP-10 Fingers Ongoing Antibody-Mediated Kidney Graft Rejection. J Am Soc Nephrol 2015;26:2607-9. [PMID: 25948874 DOI: 10.1681/ASN.2015040353] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
25 Crescioli C. Chemokines and transplant outcome. Clinical Biochemistry 2016;49:355-62. [DOI: 10.1016/j.clinbiochem.2015.07.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
26 Ruano L, Sacanell J, Roman A, Rello J. Papel de los biomarcadores en el diagnóstico diferencial de la insuficiencia respiratoria aguda en el postoperatorio inmediato del trasplante pulmonar. Medicina Intensiva 2013;37:416-22. [DOI: 10.1016/j.medin.2013.01.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
27 Rush D. Protocol Transplant Biopsies: An Underutilized Tool in Kidney Transplantation. CJASN 2005;1:138-43. [DOI: 10.2215/cjn.00390705] [Cited by in Crossref: 49] [Cited by in F6Publishing: 13] [Article Influence: 2.9] [Reference Citation Analysis]
28 Peng W, Chen J, Jiang Y, Shou Z, Chen Y, Wang H. Non-invasive Detection of Acute Renal Allograft Rejection by Measurement of Vascular Endothelial Growth Factor in Urine. J Int Med Res 2007;35:442-9. [DOI: 10.1177/147323000703500402] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
29 Seiler M, Brabcova I, Viklicky O, Hribova P, Rosenberger C, Pratschke J, Lodererova A, Matz M, Schönemann C, Reinke P, Volk H, Kotsch K. Heightened Expression of the Cytotoxicity Receptor NKG2D Correlates with Acute and Chronic Nephropathy After Kidney Transplantation. Am J Transplant 2007;7:423-33. [DOI: 10.1111/j.1600-6143.2006.01625.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 3.1] [Reference Citation Analysis]
30 Eikmans M, Roelen DL, Claas FH. Molecular monitoring for rejection and graft outcome in kidney transplantation. Expert Opinion on Medical Diagnostics 2008;2:1365-79. [DOI: 10.1517/17530050802600683] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
31 Field M, Lowe D, Cobbold M, Higgins R, Briggs D, Inston N, Ready AR. The use of NGAL and IP-10 in the prediction of early acute rejection in highly sensitized patients following HLA-incompatible renal transplantation. Transpl Int 2014;27:362-70. [DOI: 10.1111/tri.12266] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
32 Nissaisorakarn V, Lee JR, Lubetzky M, Suthanthiran M. Urine biomarkers informative of human kidney allograft rejection and tolerance. Human Immunology 2018;79:343-55. [DOI: 10.1016/j.humimm.2018.01.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
33 Millán O, Budde K, Sommerer C, Aliart I, Rissling O, Bardaji B, Matz M, Zeier M, Silva I, Guirado L, Brunet M. Urinary miR-155-5p and CXCL10 as prognostic and predictive biomarkers of rejection, graft outcome and treatment response in kidney transplantation. Br J Clin Pharmacol 2017;83:2636-50. [PMID: 28880456 DOI: 10.1111/bcp.13399] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
34 Ho J, Rush DN, Karpinski M, Storsley L, Gibson IW, Bestland J, Gao A, Stefura W, HayGlass KT, Nickerson PW. Validation of urinary CXCL10 as a marker of borderline, subclinical, and clinical tubulitis. Transplantation. 2011;92:878-882. [PMID: 21876477 DOI: 10.1097/tp.0b013e31822d4de1] [Cited by in Crossref: 55] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
35 Kwon O, Ahn K, Zhang B, Lockwood T, Dhamija R, Anderson D, Saqib N. Simultaneous monitoring of multiple urinary cytokines may predict renal and patient outcome in ischemic AKI. Renal Failure 2010;32:699-708. [DOI: 10.3109/0886022x.2010.486496] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
36 Alachkar N. Serum and urinary biomarkers in acute kidney transplant rejection. Néphrologie & Thérapeutique 2012;8:13-9. [DOI: 10.1016/j.nephro.2011.07.409] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
37 Hu H, Kwun J, Aizenstein BD, Knechtle SJ. Noninvasive detection of acute and chronic injuries in human renal transplant by elevation of multiple cytokines/chemokines in urine. Transplantation. 2009;87:1814-1820. [PMID: 19543058 DOI: 10.1097/tp.0b013e3181a66b3e] [Cited by in Crossref: 63] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
38 Sigdel T, Nguyen M, Liberto J, Dobi D, Junger H, Vincenti F, Laszik Z, Sarwal MM. Assessment of 19 Genes and Validation of CRM Gene Panel for Quantitative Transcriptional Analysis of Molecular Rejection and Inflammation in Archival Kidney Transplant Biopsies. Front Med (Lausanne) 2019;6:213. [PMID: 31632976 DOI: 10.3389/fmed.2019.00213] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
39 Townamchai N, Eiam-Ong S. Biomarkers in kidney transplantation: From bench to bedside. World J Nephrol 2015; 4(5): 487-491 [PMID: 26558185 DOI: 10.5527/wjn.v4.i5.487] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
40 Vallabhajosyula P, Korutla L, Habertheuer A, Yu M, Rostami S, Yuan CX, Reddy S, Liu C, Korutla V, Koeberlein B, Trofe-Clark J, Rickels MR, Naji A. Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue. J Clin Invest. 2017;127:1375-1391. [PMID: 28319051 DOI: 10.1172/jci87993] [Cited by in Crossref: 75] [Cited by in F6Publishing: 49] [Article Influence: 15.0] [Reference Citation Analysis]
41 Gao J, Wu L, Wang S, Chen X. Role of Chemokine (C-X-C Motif) Ligand 10 (CXCL10) in Renal Diseases. Mediators Inflamm 2020;2020:6194864. [PMID: 32089645 DOI: 10.1155/2020/6194864] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
42 Peng W, Chen J, Jiang Y, Shou Z, Chen Y, Wang H. Acute renal allograft rejection is associated with increased levels of vascular endothelial growth factor in the urine. Nephrology (Carlton). 2008;13:73-79. [PMID: 18199108 DOI: 10.1111/j.1440-1797.2007.00856.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
43 Hoerning A, Köhler S, Jun C, Lu J, Fu J, Tebbe B, Dolff S, Feldkamp T, Kribben A, Hoyer PF, Witzke O. Cyclosporin but not everolimus inhibits chemokine receptor expression on CD4+ T cell subsets circulating in the peripheral blood of renal transplant recipients. Clin Exp Immunol 2012;168:251-9. [PMID: 22471287 DOI: 10.1111/j.1365-2249.2012.04571.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
44 Colucci G, Floege J, Schena FP. The urinary sediment beyond light microscopical examination. Nephrology Dialysis Transplantation 2006;21:1482-5. [DOI: 10.1093/ndt/gfl223] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
45 Anglicheau D, Suthanthiran M. Noninvasive prediction of organ graft rejection and outcome using gene expression patterns. Transplantation. 2008;86:192-199. [PMID: 18645476 DOI: 10.1097/tp.0b013e31817eef7b] [Cited by in Crossref: 76] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
46 Alakulppi NS, Kyllönen LE, Partanen J, Salmela KT, Laine JT. Diagnosis of Acute Renal Allograft Rejection by Analyzing Whole Blood mRNA Expression of Lymphocyte Marker Molecules. Transplantation 2007;83:791-8. [DOI: 10.1097/01.tp.0000258726.13363.ab] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
47 Garg N, Samaniego MD, Clark D, Djamali A. Defining the phenotype of antibody-mediated rejection in kidney transplantation: Advances in diagnosis of antibody injury. Transplant Rev (Orlando) 2017;31:257-67. [PMID: 28882367 DOI: 10.1016/j.trre.2017.08.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
48 Lee JR, Muthukumar T, Dadhania D, Ding R, Sharma VK, Schwartz JE, Suthanthiran M. Urinary cell mRNA profiles predictive of human kidney allograft status. Immunol Rev. 2014;258:218-240. [PMID: 24517436 DOI: 10.1111/imr.12159] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
49 Ong S, Mannon RB. Genomic and proteomic fingerprints of acute rejection in peripheral blood and urine. Transplant Rev (Orlando). 2015;29:60-67. [PMID: 25542607 DOI: 10.1016/j.trre.2014.12.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
50 Watson D, Yang JYC, Sarwal RD, Sigdel TK, Liberto JM, Damm I, Louie V, Sigdel S, Livingstone D, Soh K, Chakraborty A, Liang M, Lin PC, Sarwal MM. A Novel Multi-Biomarker Assay for Non-Invasive Quantitative Monitoring of Kidney Injury. J Clin Med 2019;8:E499. [PMID: 31013714 DOI: 10.3390/jcm8040499] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
51 Cravedi P, Mannon RB. Noninvasive methods to assess the risk of kidney transplant rejection. Expert Rev Clin Immunol 2009;5:535-46. [PMID: 20161000 DOI: 10.1586/eci.09.36] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
52 Jia L, Fu W, Jia R, Wu L, Li X, Jia Q, Zhang H. Identification of potential key protein interaction networks of BK virus nephropathy in patients receiving kidney transplantation. Sci Rep 2018;8:5017. [PMID: 29567951 DOI: 10.1038/s41598-018-23492-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
53 Segerer S, Böhmig GA, Exner M, Kerjaschki D, Regele H, Schlöndorff D. Role of CXCR3 in cellular but not humoral renal allograft rejection. Transpl Int 2005;18:676-80. [PMID: 15910293 DOI: 10.1111/j.1432-2277.2005.00117.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
54 Krüger B, Banas MC, Walberer A, Böger CA, Farkas S, Hoffmann U, Fischereder M, Banas B, Krämer BK. A comprehensive genotype-phenotype interaction of different Toll-like receptor variations in a renal transplant cohort. Clin Sci (Lond) 2010;119:535-44. [PMID: 20604744 DOI: 10.1042/CS20100190] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
55 Lau AH, Turnquist HR, Tokita D, Zeevi A, Mazariegos GV, Thomson AW. “Tolerance” assays: the physician's guide to safe weaning of immunosuppression? Transplantation Reviews 2006;20:208-21. [DOI: 10.1016/j.trre.2006.09.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
56 Kim CJ, Romero R, Chaemsaithong P, Kim JS. Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance. Am J Obstet Gynecol 2015;213:S53-69. [PMID: 26428503 DOI: 10.1016/j.ajog.2015.08.041] [Cited by in Crossref: 206] [Cited by in F6Publishing: 197] [Article Influence: 29.4] [Reference Citation Analysis]
57 Barraclough KA, Staatz CE, Isbel NM, McTaggart SJ. Review: Pharmacodynamic monitoring of immunosuppression in kidney transplantation. Nephrology (Carlton). 2010;15:522-532. [PMID: 20649871 DOI: 10.1111/j.1440-1797.2010.01349.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
58 Ho J, Rush DN, Krokhin O, Antonovici M, Gao A, Bestland J, Wiebe C, Hiebert B, Rigatto C, Gibson IW, Wilkins JA, Nickerson PW. Elevated Urinary Matrix Metalloproteinase-7 Detects Underlying Renal Allograft Inflammation and Injury. Transplantation 2016;100:648-54. [DOI: 10.1097/tp.0000000000000867] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
59 Hoffman SA, Wang L, Shah CV, Ahya VN, Pochettino A, Olthoff K, Shaked A, Wille K, Lama VN, Milstone A, Ware LB, Orens J, Weinacker A, Demissie E, Bellamy S, Kawut SM, Hancock WW, Christie JD; Lung Transplant Outcomes Group. Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation. Am J Transplant 2009;9:389-96. [PMID: 19120076 DOI: 10.1111/j.1600-6143.2008.02497.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 4.9] [Reference Citation Analysis]
60 Mockler C, Sharma A, Gibson IW, Gao A, Wong A, Ho J, Blydt-Hansen TD. The prognostic value of urinary chemokines at 6 months after pediatric kidney transplantation. Pediatr Transplant 2018;22:e13205. [PMID: 29733487 DOI: 10.1111/petr.13205] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
61 Mannon RB. Immune monitoring and biomarkers to predict chronic allograft dysfunction. Kidney Int Suppl 2010;:S59-65. [PMID: 21116320 DOI: 10.1038/ki.2010.425] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
62 Moreau A, Varey E, Anegon I, Cuturi MC. Effector mechanisms of rejection. Cold Spring Harb Perspect Med. 2013;3. [PMID: 24186491 DOI: 10.1101/cshperspect.a015461] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 8.1] [Reference Citation Analysis]
63 Ho J, Wiebe C, Gibson IW, Rush DN, Nickerson PW. Immune Monitoring of Kidney Allografts. American Journal of Kidney Diseases 2012;60:629-40. [DOI: 10.1053/j.ajkd.2012.01.028] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
64 Cibrik DM, Warner RL, Kommareddi M, Song P, Luan FL, Johnson KJ. Identification of a protein signature in renal allograft rejection. Proteomics Clin Appl. 2013;7:839-849. [PMID: 24323459 DOI: 10.1002/prca.201200036] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
65 Taheri S, Asim M, Al Malki H, Fituri O, Suthanthiran M, August P; IDEAL-2 Study Team. Intervention using vitamin D for elevated urinary albumin in type 2 diabetes mellitus (IDEAL-2 Study): study protocol for a randomised controlled trial. Trials 2018;19:230. [PMID: 29665833 DOI: 10.1186/s13063-018-2616-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
66 Raju TR, Madhavi NV, Sridhar GR. The eye and the kidney: twin targets in diabetes. Int J Diabetes Dev Ctries 2015;35:299-302. [DOI: 10.1007/s13410-015-0461-6] [Reference Citation Analysis]
67 Meng X, Gao W, Tang Y, Shen Z, Wang Z. Alterations of Serum IP-10 and TARC in Patients with Early Acute Rejection after Liver Transplantation. Cell Physiol Biochem 2017;41:1063-71. [DOI: 10.1159/000464114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
68 Szeto CC, Tam LS, Kwan BC, Lai KB, Wang G, Li EK, Chow KM, Lai FM, Li PK. Monitoring of urinary messenger RNA levels for the prediction of flare in systemic lupus erythematosus. Clin Chim Acta 2012;413:448-55. [PMID: 22120729 DOI: 10.1016/j.cca.2011.10.030] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
69 Hu H, Knechtle SJ. Elevation of multiple cytokines/chemokines in urine of human renal transplant recipients with acute and chronic injuries: potential usage for diagnosis and monitoring. Transplantation Reviews 2006;20:165-71. [DOI: 10.1016/j.trre.2006.07.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
70 Gillespie A, Lee IJ. Biomarkers in renal transplantation. Biomark Med 2008;2:603-12. [PMID: 20477449 DOI: 10.2217/17520363.2.6.603] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
71 Chowdhury P, Hernandez-Fuentes MP. Non-invasive biomarkers to guide management following renal transplantation: the need for a multiplatform approach. Curr Opin Organ Transplant 2013;18:1-5. [PMID: 23283248 DOI: 10.1097/MOT.0b013e32835c8025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
72 Galante NZ, Câmara NOS, Kallas EG, Salomão R, Pacheco-silva A, Medina-pestana JO. Noninvasive immune monitoring assessed by flow cytometry and real time RT-PCR in urine of renal transplantation recipients. Transplant Immunology 2006;16:73-80. [DOI: 10.1016/j.trim.2006.03.014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
73 Sánchez-Fueyo A, Strom TB. Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs. Gastroenterology. 2011;140:51-64. [PMID: 21073873 DOI: 10.1053/j.gastro.2010.10.059] [Cited by in Crossref: 156] [Cited by in F6Publishing: 129] [Article Influence: 13.0] [Reference Citation Analysis]
74 Menon MC, Keung KL, Murphy B, OʼConnell PJ. The Use of Genomics and Pathway Analysis in Our Understanding and Prediction of Clinical Renal Transplant Injury. Transplantation 2016;100:1405-14. [PMID: 26447506 DOI: 10.1097/TP.0000000000000943] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
75 Hoffmann U, Segerer S, Rümmele P, Krüger B, Pietrzyk M, Hofstädter F, Banas B, Krämer BK. Expression of the chemokine receptor CXCR3 in human renal allografts—a prospective study. Nephrology Dialysis Transplantation 2006;21:1373-81. [DOI: 10.1093/ndt/gfk075] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
76 Raza A, Firasat S, Khaliq S, Aziz T, Mubarak M, Naqvi SAA, Mehdi SQ, Rizvi SA, Abid A. The association of urinary interferon-gamma inducible protein-10 (IP10/CXCL10) levels with kidney allograft rejection. Inflamm Res 2017;66:425-32. [DOI: 10.1007/s00011-017-1025-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
77 Zhang Q, Liu YF, Su ZX, Shi LP, Chen YH. Serum fractalkine and interferon-gamma inducible protein-10 concentrations are early detection markers for acute renal allograft rejection. Transplant Proc 2014;46:1420-5. [PMID: 24935307 DOI: 10.1016/j.transproceed.2014.02.019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
78 Ting Y, Coates PT, Walker RJ, Mclellan AD. Urinary tubular biomarkers as potential early predictors of renal allograft rejection: Tubular biomarkers for transplant rejection. Nephrology 2012;17:11-6. [DOI: 10.1111/j.1440-1797.2011.01536.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
79 Menon MC, Murphy B, Heeger PS. Moving Biomarkers toward Clinical Implementation in Kidney Transplantation. J Am Soc Nephrol 2017;28:735-47. [PMID: 28062570 DOI: 10.1681/ASN.2016080858] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 5.6] [Reference Citation Analysis]
80 Sawitzki B, Schlickeiser S, Reinke P, Volk HD. Monitoring tolerance and rejection in organ transplant recipients. Biomarkers. 2011;16 Suppl 1:S42-S50. [PMID: 21707443 DOI: 10.3109/1354750x.2011.578754] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
81 Øzbay A, Tørring C, Olsen R, Carstens J. Transcriptional Profiles in Urine During Acute Rejection, Bacteriuria, CMV Infection and Stable Graft Function After Renal Transplantation. Scandinavian Journal of Immunology 2009;69:357-65. [DOI: 10.1111/j.1365-3083.2009.02226.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
82 Schmuck RB, Reutzel-selke A, Raschzok N, Morgul HM, Struecker B, Lippert S, de Carvalho Fischer C, Schmelzle M, Boas-knoop S, Bahra M, Pascher A, Pratschke J, Sauer IM. Bile: miRNA pattern and protein-based biomarkers may predict acute cellular rejection after liver transplantation. Biomarkers 2016;22:19-27. [DOI: 10.1080/1354750x.2016.1201538] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
83 [DOI: 10.1117/12.2054976] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
84 Keslar KS, Lin M, Zmijewska AA, Sigdel TK, Tran TQ, Ma L, Bhasin M, Rao P, Ding R, Iklé DN, Mannon RB, Sarwal MM, Strom TB, Reed EF, Heeger PS, Suthanthiran M, Fairchild RL. Multicenter evaluation of a standardized protocol for noninvasive gene expression profiling. Am J Transplant 2013;13:1891-7. [PMID: 23802725 DOI: 10.1111/ajt.12284] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
85 De Serres SA, Varghese JC, Levin A. Biomarkers in native and transplant kidneys: opportunities to improve prediction of outcomes in chronic kidney disease. Curr Opin Nephrol Hypertens 2012;21:619-27. [PMID: 22914685 DOI: 10.1097/MNH.0b013e32835846e3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
86 Mas VR, Mas LA, Archer KJ, Yanek K, King AL, Gibney EM, Cotterell A, Fisher RA, Posner M, Maluf DG. Evaluation of gene panel mRNAs in urine samples of kidney transplant recipients as a non-invasive tool of graft function. Mol Med 2007;13:315-24. [PMID: 17622313 DOI: 10.2119/2007–00017.Mas] [Cited by in Crossref: 21] [Article Influence: 1.4] [Reference Citation Analysis]
87 Romagnani P, Crescioli C. CXCL10: a candidate biomarker in transplantation. Clin Chim Acta 2012;413:1364-73. [PMID: 22366165 DOI: 10.1016/j.cca.2012.02.009] [Cited by in Crossref: 72] [Cited by in F6Publishing: 70] [Article Influence: 7.2] [Reference Citation Analysis]
88 Matz M, Beyer J, Wunsch D, Mashreghi MF, Seiler M, Pratschke J, Babel N, Volk HD, Reinke P, Kotsch K. Early post-transplant urinary IP-10 expression after kidney transplantation is predictive of short- and long-term graft function. Kidney Int. 2006;69:1683-1690. [PMID: 16572110 DOI: 10.1038/sj.ki.5000343] [Cited by in Crossref: 113] [Cited by in F6Publishing: 104] [Article Influence: 7.1] [Reference Citation Analysis]
89 Hartono C, Muthukumar T, Suthanthiran M. Noninvasive diagnosis of acute rejection of renal allografts. Curr Opin Organ Transplant 2010;15:35-41. [PMID: 19935064 DOI: 10.1097/MOT.0b013e3283342728] [Cited by in Crossref: 61] [Cited by in F6Publishing: 27] [Article Influence: 5.1] [Reference Citation Analysis]
90 Jang HR, Kim M, Hong S, Lee K, Park MY, Yang KE, Lee CJ, Jeon J, Lee KW, Lee JE, Park JB, Kim K, Kwon GY, Kim YG, Kim DJ, Huh W. Early postoperative urinary MCP-1 as a potential biomarker predicting acute rejection in living donor kidney transplantation: a prospective cohort study. Sci Rep 2021;11:18832. [PMID: 34552150 DOI: 10.1038/s41598-021-98135-0] [Reference Citation Analysis]
91 Crowley LE, Mekki M, Chand S. Biomarkers and Pharmacogenomics in Kidney Transplantation. Mol Diagn Ther 2018;22:537-50. [PMID: 29971647 DOI: 10.1007/s40291-018-0349-5] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
92 Övünç Hacıhamdioğlu D, Zeybek C, Gök F, Pekel A, Muşabak U. Elevated Urinary T Helper 1 Chemokine Levels in Newly Diagnosed Hypertensive Obese Children. J Clin Res Pediatr Endocrinol 2015;7:175-82. [PMID: 26831550 DOI: 10.4274/jcrpe.1917] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
93 Wang G, Szeto C. Quantification of gene expression in urinary sediment for the study of renal diseases. Nephrology 2007;12:494-9. [DOI: 10.1111/j.1440-1797.2007.00836.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
94 Gwinner W. Renal transplant rejection markers. World J Urol. 2007;25:445-455. [PMID: 17786452 DOI: 10.1007/s00345-007-0211-6] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
95 Manzia TM, Gazia C, Baiocchi L, Lenci I, Milana M, Santopaolo F, Angelico R, Tisone G. Clinical Operational Tolerance and Immunosuppression Minimization in Kidney Transplantation: Where Do We Stand? RRCT 2019;14:189-202. [DOI: 10.2174/1574887114666190313170205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
96 Mas VR, Maluf DG, Archer KJ, Yanek K, King A, Cotterell A, Ferreira-Gonzalez A, Rodgers C, Fisher RA, Posner M. Study of mRNA growth factors in urinary cells of kidney transplant recipients as predictors of chronic allograft nephropathy. Transplantation 2005;80:1686-91. [PMID: 16378062 DOI: 10.1097/01.tp.0000185472.79948.db] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
97 Hoerning A, Koss K, Datta D, Boneschansker L, Jones CN, Wong IY, Irimia D, Calzadilla K, Benitez F, Hoyer PF, Harmon WE, Briscoe DM. Subsets of human CD4(+) regulatory T cells express the peripheral homing receptor CXCR3. Eur J Immunol 2011;41:2291-302. [PMID: 21538345 DOI: 10.1002/eji.201041095] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 4.4] [Reference Citation Analysis]
98 Girlanda R, Mannon RB, Kirk AD. Diagnostic Tools for Monitoring Kidney Transplant Recipients. Seminars in Nephrology 2007;27:462-78. [DOI: 10.1016/j.semnephrol.2007.03.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
99 Dooley BJ, Verma A, Ding R, Yang H, Muthukumar T, Lubetzky M, Shankaranarayanan D, Elemento O, Suthanthiran M. Urinary Cell Transcriptome Profiling and Identification of ITM2A, SLAMF6, and IKZF3 as Biomarkers of Acute Rejection in Human Kidney Allografts. Transplant Direct 2020;6:e588. [PMID: 32766436 DOI: 10.1097/TXD.0000000000001035] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
100 Mas VR, Mas LA, Archer KJ, Yanek K, King AL, Gibney EM, Cotterell A, Fisher RA, Posner M, Maluf DG. Evaluation of gene panel mRNAs in urine samples of kidney transplant recipients as a non-invasive tool of graft function. Mol Med 2007;13:315-24. [PMID: 17622313 DOI: 10.2119/2007–00017.Mas] [Cited by in Crossref: 23] [Article Influence: 1.5] [Reference Citation Analysis]
101 Tantisattamo E, Leventhal JR, Mathew JM, Gallon L. Chimerism and tolerance: past, present and future strategies to prolong renal allograft survival. Curr Opin Nephrol Hypertens 2021;30:63-74. [PMID: 33186221 DOI: 10.1097/MNH.0000000000000666] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Romero R, Chaemsaithong P, Chaiyasit N, Docheva N, Dong Z, Kim CJ, Kim YM, Kim JS, Qureshi F, Jacques SM, Yoon BH, Chaiworapongsa T, Yeo L, Hassan SS, Erez O, Korzeniewski SJ. CXCL10 and IL-6: Markers of two different forms of intra-amniotic inflammation in preterm labor. Am J Reprod Immunol 2017;78. [PMID: 28544362 DOI: 10.1111/aji.12685] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 7.2] [Reference Citation Analysis]
103 Mannon RB, Kirk AD. Beyond histology: novel tools to diagnose allograft dysfunction. Clin J Am Soc Nephrol 2006;1:358-66. [PMID: 17699232 DOI: 10.2215/CJN.01681105] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
104 García-Covarrubias L, Ventura E, Soto V, González E, García A, Aguilar JC, Torres JM, Hinojosa H, Fragoso P, De Los Santos J, Ortuño D, San Cristóbal P, Díliz H. Lack of Association Between Elevated Urinary Levels of Interleukin-10 and Interferon Gamma With the Presence of Inflammation in Kidney Transplant Recipients. Transplant Proc 2016;48:583-7. [PMID: 27110008 DOI: 10.1016/j.transproceed.2016.02.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
105 Verma A, Muthukumar T, Yang H, Lubetzky M, Cassidy MF, Lee JR, Dadhania DM, Snopkowski C, Shankaranarayanan D, Salvatore SP, Sharma VK, Xiang JZ, De Vlaminck I, Seshan SV, Mueller FB, Suhre K, Elemento O, Suthanthiran M. Urinary cell transcriptomics and acute rejection in human kidney allografts. JCI Insight 2020;5:131552. [PMID: 32102984 DOI: 10.1172/jci.insight.131552] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
106 Erpicum P, Hanssen O, Weekers L, Lovinfosse P, Meunier P, Tshibanda L, Krzesinski JM, Hustinx R, Jouret F. Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients, part II: omics analyses of urine and blood samples. Clin Kidney J 2017;10:106-15. [PMID: 28643819 DOI: 10.1093/ckj/sfw077] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
107 Szeto CC, Kwan BC, Tam LS. Urinary mRNA in systemic lupus erythematosus. Adv Clin Chem 2013;62:197-219. [PMID: 24772668 DOI: 10.1016/b978-0-12-800096-0.00005-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
108 Mengel M. Renalomics: Molecular Pathology in Kidney Biopsies. Surg Pathol Clin 2014;7:443-55. [PMID: 26837449 DOI: 10.1016/j.path.2014.04.005] [Reference Citation Analysis]
109 Kuypers DR. Immunosuppressive drug therapy and subclinical acute renal allograft rejection: impact and effect. Transplantation 2008;85:S25-30. [PMID: 18401259 DOI: 10.1097/TP.0b013e318169c48d] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
110 Mas V, Maluf D, Archer K, Yanek K, Mas L, King A, Gibney E, Massey D, Cotterell A, Fisher R. Establishing the molecular pathways involved in chronic allograft nephropathy for testing new noninvasive diagnostic markers. Transplantation. 2007;83:448-457. [PMID: 17318078 DOI: 10.1097/01.tp.0000251373.17997.9a] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 3.9] [Reference Citation Analysis]
111 Aquino-Dias EC, Joelsons G, da Silva DM, Berdichevski RH, Ribeiro AR, Veronese FJ, Gonçalves LF, Manfro RC. Non-invasive diagnosis of acute rejection in kidney transplants with delayed graft function. Kidney Int. 2008;73:877-884. [PMID: 18216781 DOI: 10.1038/sj.ki.5002795] [Cited by in Crossref: 73] [Cited by in F6Publishing: 60] [Article Influence: 5.2] [Reference Citation Analysis]
112 Gandolfi BM, Leitman IM. A blood test for acute rejection after renal transplantation? Commentary on “Osteopontin level correlates with acute cellular renal allograft rejection”. Journal of Surgical Research 2013;185:e49-50. [DOI: 10.1016/j.jss.2012.08.056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
113 Ho J, Rush DN, Nickerson PW. Urinary biomarkers of renal transplant outcome: . Current Opinion in Organ Transplantation 2015;20:476-81. [DOI: 10.1097/mot.0000000000000208] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
114 Sawitzki B, Reinke P, Pascher A, Volk H. State of the art on the research for biomarkers allowing individual, tailor-made minimization of immunosuppression. Current Opinion in Organ Transplantation 2010;15:691-6. [DOI: 10.1097/mot.0b013e32834066b0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
115 Blydt-Hansen TD, Gibson IW, Gao A, Dufault B, Ho J. Elevated urinary CXCL10-to-creatinine ratio is associated with subclinical and clinical rejection in pediatric renal transplantation. Transplantation. 2015;99:797-804. [PMID: 25222013 DOI: 10.1097/tp.0000000000000419] [Cited by in Crossref: 38] [Cited by in F6Publishing: 16] [Article Influence: 5.4] [Reference Citation Analysis]
116 Lubetzky ML, Salinas T, Schwartz JE, Suthanthiran M. Urinary Cell mRNA Profiles Predictive of Human Kidney Allograft Status. Clin J Am Soc Nephrol 2021:CJN. [PMID: 33906907 DOI: 10.2215/CJN.14010820] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
117 Mas VR, Archer KJ, Scian M, Maluf DG. Molecular pathways involved in loss of graft function in kidney transplant recipients. Expert Rev Mol Diagn 2010;10:269-84. [PMID: 20370585 DOI: 10.1586/erm.10.6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
118 Vaidya VS, Waikar SS, Ferguson MA, Collings FB, Sunderland K, Gioules C, Bradwin G, Matsouaka R, Betensky RA, Curhan GC, Bonventre JV. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci 2008;1:200-8. [PMID: 19212447 DOI: 10.1111/j.1752-8062.2008.00053.x] [Cited by in Crossref: 239] [Cited by in F6Publishing: 215] [Article Influence: 19.9] [Reference Citation Analysis]
119 Arnau A, Benito-Hernández A, Ramos-Barrón MA, García-Unzueta MT, Gómez-Román JJ, Gómez-Ortega JM, López-Hoyos M, San Segundo D, Ruiz JC, Rodrigo E. Urinary C-X-C Motif Chemokine 10 Is Related to Acute Graft Lesions Secondary to T Cell- and Antibody-Mediated Damage. Ann Transplant 2021;26:e929491. [PMID: 33686050 DOI: 10.12659/AOT.929491] [Reference Citation Analysis]
120 Ho J, Sharma A, Kroeker K, Carroll R, De Serres S, Gibson IW, Hirt-Minkowski P, Jevnikar A, Kim SJ, Knoll G, Rush DN, Wiebe C, Nickerson P. Multicentre randomised controlled trial protocol of urine CXCL10 monitoring strategy in kidney transplant recipients. BMJ Open 2019;9:e024908. [PMID: 30975673 DOI: 10.1136/bmjopen-2018-024908] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
121 Butt AN, Swaminathan R. Overview of Circulating Nucleic Acids in Plasma/Serum. Annals of the New York Academy of Sciences 2008;1137:236-42. [DOI: 10.1196/annals.1448.002] [Cited by in Crossref: 81] [Cited by in F6Publishing: 77] [Article Influence: 5.8] [Reference Citation Analysis]
122 Mannon RB, Hoffmann SC, Kampen RL, Cheng OC, Kleiner DE, Ryschkewitsch C, Curfman B, Major E, Hale DA, Kirk AD. Molecular evaluation of BK polyomavirus nephropathy. Am J Transplant 2005;5:2883-93. [PMID: 16303001 DOI: 10.1111/j.1600-6143.2005.01096.x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 76] [Article Influence: 5.4] [Reference Citation Analysis]
123 Schenk AD, Rosenblum JM, Fairchild RL. Chemokine-directed strategies to attenuate allograft rejection. Clin Lab Med 2008;28:441-54, vii. [PMID: 19028262 DOI: 10.1016/j.cll.2008.07.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
124 Sigdel TK, Bestard O, Tran TQ, Hsieh SC, Roedder S, Damm I, Vincenti F, Sarwal MM. A Computational Gene Expression Score for Predicting Immune Injury in Renal Allografts. PLoS One. 2015;10:e0138133. [PMID: 26367000 DOI: 10.1371/journal.pone.0138133] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
125 Hirt-Minkowski P, De Serres SA, Ho J. Developing renal allograft surveillance strategies - urinary biomarkers of cellular rejection. Can J Kidney Health Dis. 2015;2:28. [PMID: 26285614 DOI: 10.1186/s40697-015-0061-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
126 Hauser IA, Spiegler S, Kiss E, Gauer S, Sichler O, Scheuermann EH, Ackermann H, Pfeilschifter JM, Geiger H, Gröne H, Radeke HH. Prediction of Acute Renal Allograft Rejection by Urinary Monokine Induced by IFN-γ (MIG). JASN 2005;16:1849-58. [DOI: 10.1681/asn.2004100836] [Cited by in Crossref: 85] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
127 Schlickeiser S, Boës D, Streitz M, Sawitzki B. The use of novel diagnostics to individualize immunosuppression following transplantation. Transpl Int 2015;28:911-20. [PMID: 25611562 DOI: 10.1111/tri.12527] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
128 Bradley BA. Prognostic assays for rejection and tolerance in organ transplantation. Transpl Immunol 2005;14:193-201. [PMID: 15982563 DOI: 10.1016/j.trim.2005.03.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
129 Jackson JA, Kim EJ, Begley B, Cheeseman J, Harden T, Perez SD, Thomas S, Warshaw B, Kirk AD. Urinary chemokines CXCL9 and CXCL10 are noninvasive markers of renal allograft rejection and BK viral infection. Am J Transplant. 2011;11:2228-2234. [PMID: 21812928 DOI: 10.1111/j.1600-6143.2011.03680.x] [Cited by in Crossref: 114] [Cited by in F6Publishing: 101] [Article Influence: 10.4] [Reference Citation Analysis]
130 Gotsch F, Romero R, Friel L, Kusanovic JP, Espinoza J, Erez O, Than NG, Mittal P, Edwin S, Yoon BH, Kim CJ, Mazaki-Tovi S, Chaiworapongsa T, Hassan SS. CXCL10/IP-10: a missing link between inflammation and anti-angiogenesis in preeclampsia? J Matern Fetal Neonatal Med 2007;20:777-92. [PMID: 17943641 DOI: 10.1080/14767050701483298] [Cited by in Crossref: 72] [Cited by in F6Publishing: 73] [Article Influence: 5.1] [Reference Citation Analysis]
131 Merani S, Truong WW, Hancock W, Anderson CC, Shapiro AMJ. Chemokines and Their Receptors in Islet Allograft Rejection and as Targets for Tolerance Induction. Cell Transplant 2006;15:295-309. [PMID: 28863747 DOI: 10.3727/000000006783981963] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
132 Sawitzki B, Pascher A, Babel N, Reinke P, Volk H. Can We Use Biomarkers and Functional Assays to Implement Personalized Therapies in Transplantation? Transplantation 2009;87:1595-601. [DOI: 10.1097/tp.0b013e3181a6b2cf] [Cited by in Crossref: 22] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
133 Danger R, Sawitzki B, Brouard S. Immune monitoring in renal transplantation: The search for biomarkers. Eur J Immunol 2016;46:2695-704. [PMID: 27861809 DOI: 10.1002/eji.201545963] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
134 Maymon E, Romero R, Bhatti G, Chaemsaithong P, Gomez-Lopez N, Panaitescu B, Chaiyasit N, Pacora P, Dong Z, Hassan SS, Erez O. Chronic inflammatory lesions of the placenta are associated with an up-regulation of amniotic fluid CXCR3: A marker of allograft rejection. J Perinat Med 2018;46:123-37. [PMID: 28829757 DOI: 10.1515/jpm-2017-0042] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
135 Zhou L, Tang L, Song AT, Cibrik DM, Song PX. A LASSO Method to Identify Protein Signature Predicting Post-transplant Renal Graft Survival. Stat Biosci. 2017;9:431-452. [PMID: 29399205 DOI: 10.1007/s12561-016-9170-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
136 van de Berg PJ, Yong SL, Koch SD, Lardy N, van Donselaar-van der Pant KA, Florquin S, Bemelman FJ, van Lier RA, ten Berge IJ. Characteristics of alloreactive T cells measured before renal transplantation. Clin Exp Immunol 2012;168:241-50. [PMID: 22471286 DOI: 10.1111/j.1365-2249.2011.04551.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
137 Ho J, Sharma A, Mandal R, Wishart DS, Wiebe C, Storsley L, Karpinski M, Gibson IW, Nickerson PW, Rush DN. Detecting Renal Allograft Inflammation Using Quantitative Urine Metabolomics and CXCL10. Transplant Direct 2016;2:e78. [PMID: 27500268 DOI: 10.1097/TXD.0000000000000589] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
138 Böhmig GA, Wahrmann M, Säemann MD. Detecting adaptive immunity: applications in transplantation monitoring. Mol Diagn Ther 2010;14:1-11. [PMID: 20121285 DOI: 10.1007/BF03256348] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
139 Behnam Sani K, Sawitzki B. Immune monitoring as prerequisite for transplantation tolerance trials. Clin Exp Immunol 2017;189:158-70. [PMID: 28518214 DOI: 10.1111/cei.12988] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
140 Schmid H, Henger A, Kretzler M. Molecular approaches to chronic kidney disease. Curr Opin Nephrol Hypertens 2006;15:123-9. [PMID: 16481877 DOI: 10.1097/01.mnh.0000214770.11609.fb] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
141 Anglicheau D, Naesens M, Essig M, Gwinner W, Marquet P. Establishing Biomarkers in Transplant Medicine: A Critical Review of Current Approaches. Transplantation. 2016;100:2024-2038. [PMID: 27479159 DOI: 10.1097/tp.0000000000001321] [Cited by in Crossref: 41] [Cited by in F6Publishing: 23] [Article Influence: 8.2] [Reference Citation Analysis]